Cargando…
Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
α(2)-Macroglobulin (α(2)M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α(2)M with proteases results in an ‘activated’ conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α(2)M....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science B.V
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581772/ https://www.ncbi.nlm.nih.gov/pubmed/23353684 http://dx.doi.org/10.1016/j.febslet.2013.01.020 |
_version_ | 1782260512829997056 |
---|---|
author | Wyatt, Amy R. Constantinescu, Patrick Ecroyd, Heath Dobson, Christopher M. Wilson, Mark R. Kumita, Janet R. Yerbury, Justin J. |
author_facet | Wyatt, Amy R. Constantinescu, Patrick Ecroyd, Heath Dobson, Christopher M. Wilson, Mark R. Kumita, Janet R. Yerbury, Justin J. |
author_sort | Wyatt, Amy R. |
collection | PubMed |
description | α(2)-Macroglobulin (α(2)M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α(2)M with proteases results in an ‘activated’ conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α(2)M. This study investigates, the effect of activation on the ability of α(2)M to inhibit amyloid formation by Aβ(1–42) and I59T human lysozyme and shows that protease-activated α(2)M can act via two distinct mechanisms: (i) by trapping proteases that remain able to degrade polypeptide chains and (ii) by a chaperone action that prevents misfolded clients from continuing along the amyloid forming pathway. STRUCTURED SUMMARY OF PROTEIN INTERACTIONS: Aβ(1–42) and Aβ(1–42) bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by light scattering (View interaction)I59T lysozyme and I59T lysozyme bind by fluorescence technology (View interaction)Alpha-lactalbumin and Alpha-lactalbumin bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by electron microscopy (View interaction)Aβ(1–42) and Aβ(1–42) bind by electron microscopy (View interaction) |
format | Online Article Text |
id | pubmed-3581772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier Science B.V |
record_format | MEDLINE/PubMed |
spelling | pubmed-35817722013-03-01 Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms Wyatt, Amy R. Constantinescu, Patrick Ecroyd, Heath Dobson, Christopher M. Wilson, Mark R. Kumita, Janet R. Yerbury, Justin J. FEBS Lett Article α(2)-Macroglobulin (α(2)M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α(2)M with proteases results in an ‘activated’ conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α(2)M. This study investigates, the effect of activation on the ability of α(2)M to inhibit amyloid formation by Aβ(1–42) and I59T human lysozyme and shows that protease-activated α(2)M can act via two distinct mechanisms: (i) by trapping proteases that remain able to degrade polypeptide chains and (ii) by a chaperone action that prevents misfolded clients from continuing along the amyloid forming pathway. STRUCTURED SUMMARY OF PROTEIN INTERACTIONS: Aβ(1–42) and Aβ(1–42) bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by light scattering (View interaction)I59T lysozyme and I59T lysozyme bind by fluorescence technology (View interaction)Alpha-lactalbumin and Alpha-lactalbumin bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by electron microscopy (View interaction)Aβ(1–42) and Aβ(1–42) bind by electron microscopy (View interaction) Elsevier Science B.V 2013-03-01 /pmc/articles/PMC3581772/ /pubmed/23353684 http://dx.doi.org/10.1016/j.febslet.2013.01.020 Text en © 2013 Elsevier B.V. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license |
spellingShingle | Article Wyatt, Amy R. Constantinescu, Patrick Ecroyd, Heath Dobson, Christopher M. Wilson, Mark R. Kumita, Janet R. Yerbury, Justin J. Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms |
title | Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms |
title_full | Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms |
title_fullStr | Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms |
title_full_unstemmed | Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms |
title_short | Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms |
title_sort | protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581772/ https://www.ncbi.nlm.nih.gov/pubmed/23353684 http://dx.doi.org/10.1016/j.febslet.2013.01.020 |
work_keys_str_mv | AT wyattamyr proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms AT constantinescupatrick proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms AT ecroydheath proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms AT dobsonchristopherm proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms AT wilsonmarkr proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms AT kumitajanetr proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms AT yerburyjustinj proteaseactivatedalpha2macroglobulincaninhibitamyloidformationviatwodistinctmechanisms |